PROS1 and cancer: Poor clinicopathologic outcomes of PTC, such as extrathyroidal extension, multifocality, larger tumor size, advanced tumor classification, lymph node metastasis, and advanced AJCC tumor, node, metastasis (staging system for cancer) stage, were strongly associated with low PROS1 expression.